How drugs and psycho-pharmacology changed mental health | Andrew Scull and Lex Fridman
Andrew Scull traces the accidental discovery of psychopharmacology, beginning with chlorpromazine's unexpected psychiatric effects in the 1950s, and discusses how pharmaceutical companies transformed mental health treatment while also introducing serious side effects like tardive dyskinesia and metabolic complications that remain inadequately addressed.
Summary
Scull explains that drugs were historically used in mental hospitals only for sedation and control, not to treat underlying mental illness. The revolution began accidentally when French Navy lieutenant Allaire Laborit discovered that chlorpromazine, an antihistamine synthesized in the 1880s, had calming effects on surgical patients—he described it as working like a "chemical lobotomy." Psychiatrists Delay and Deniker at Paris's Sainte-Anne's Hospital tested it on psychiatric patients with dramatic results: patients stopped acting out and became calmer, though the mechanism was poorly understood.
The drug emerged from post-WWII pharmaceutical expansion, particularly following penicillin's success. Rhône-Poulenc initially marketed chlorpromazine for various uses (antiemetic, eczema treatment) in an unregulated environment with no controls on drug investigation. Smith Kline & French acquired American rights and, crucially, sold it to state legislators and politicians through moving pictures of agitated patients becoming calm—establishing what would become the pharmaceutical marketing playbook. Within two years of FDA approval in 1954, 2 million Americans were taking the drug, transforming SK&F from a small operator into a major pharmaceutical company.
Initially called "major tranquilizers," these drugs were renamed "antipsychotics" in the early 1960s, suggesting they attacked underlying psychosis. They did reduce positive symptoms (hallucinations, delusions, agitation) in some patients, but did nothing for negative symptoms (apathy, social withdrawal, poverty of language). However, serious side effects were initially ignored: akathisia (incurable restlessness), Parkinson's-like symptoms, and tardive dyskinesia—irreversible jerky, uncontrolled movements of the body and facial muscles that made patients appear mentally ill on the street.
George Crane's 1974 Science paper finally highlighted these iatrogenic harms, yet solutions were limited. Clozapine, developed in 1957, didn't cause tardive dyskinesia but destroyed white blood cells in some patients and never reached America. As tardive dyskinesia became acute in the 1980s, clozapine was revived with mandatory weekly blood monitoring. This spawned "second generation antipsychotics" (Risperdal, Zyprexa, Librium, Valium), marketed as improvements but with different side effect profiles: massive weight gain (10-50 lbs), metabolic syndrome, and diabetes.
Scull emphasizes the lack of biological markers to predict individual response or side effects. The 2005 CATIE study—funded by NIH rather than industry—revealed that first-generation drugs were equally efficacious as expensive second-generation drugs, and 67-82% of patients dropped out due to inefficacy or intolerable side effects. Scull stresses that some patients prefer tolerating hallucinations to losing the "richness of their mental life" from medication effects, highlighting how psychiatric side effects are harder to quantify and describe than physical ones. He concludes there is no "free lunch" in medicine: every drug involves cost-benefit analysis with unpredictable individual outcomes.
About this episode
Lex Fridman Podcast full episode: https://www.youtube.com/watch?v=s7d2d8FhevU Thank you for listening ❤ Check out our sponsors: https://lexfridman.com/sponsors/cv10061-sb See below for guest bio, transcript, links, and to give feedback, submit questions, contact Lex, etc. *GUEST BIO:* Andrew Scull is a historian of psychiatry. *Transcript:* https://lexfridman.com/andrew-scull-transcript *CONTACT LEX:* *Feedback* - give feedback to Lex: https://lexfridman.com/survey *AMA* - submit questions, videos or call-in: https://lexfridman.com/ama *Hiring* - join our team: https://lexfridman.com/hiring *Other* - other ways to get in touch: https://lexfridman.com/contact *EPISODE LINKS:* Andrew's Website (UCSD faculty page): https://sociology.ucsd.edu/people/faculty/emeritus/andrew-scull.html Desperate Remedies (book): https://amzn.to/4vmBquI Madness in Civilization (book): https://amzn.to/3SZhd0I *SPONSORS:* To support this podcast, check out our sponsors & get discounts: *Wispr Flow:* AI-powered voice dictation app. Go to https://lexfridman.com/s/wispr_flow-cv10061-sb *Fin:* AI agent for customer service. Go to https://lexfridman.com/s/fin-cv10061-sb *LMNT:* Zero-sugar electrolyte drink mix. Go to https://lexfridman.com/s/lmnt-cv10061-sb *Shopify:* Sell stuff online. Go to https://lexfridman.com/s/shopify-cv10061-sb *BetterHelp:* Online therapy and counseling. Go to https://lexfridman.com/s/betterhelp-cv10061-sb *Perplexity:* AI-powered answer engine. Go to https://lexfridman.com/s/perplexity-cv10061-sb *PODCAST LINKS:* - Podcast Website: https://lexfridman.com/podcast - Apple Podcasts: https://apple.co/2lwqZIr - Spotify: https://spoti.fi/2nEwCF8 - RSS: https://lexfridman.com/feed/podcast/ - Podcast Playlist: https://www.youtube.com/playlist?list=PLrAXtmErZgOdP_8GztsuKi9nrraNbKKp4 - Clips Channel: https://www.youtube.com/lexclips *SOCIAL LINKS:* - X: https://x.com/lexfridman - Instagram: https://instagram.com/lexfridman - TikTok: https://tiktok.com/@lexfridman - LinkedIn: https://linkedin.com/in/lexfridman - Facebook: https://facebook.com/lexfridman - Patreon: https://patreon.com/lexfridman - Telegram: https://t.me/lexfridman - Reddit: https://reddit.com/r/lexfridman
Key Insights
- Chlorpromazine was discovered accidentally when Allaire Laborit observed it made surgical patients indifferent to their upcoming procedures and described it as working like a 'chemical lobotomy,' leading psychiatrists to test it on psychiatric patients rather than from intentional targeting of psychiatric symptoms
- Pharmaceutical companies, not hospital psychiatrists, recognized the market potential of antipsychotics and successfully marketed them to state legislators using moving pictures of agitated patients becoming calm, transforming the drug sales approach into what became modern pharmaceutical marketing
- Tardive dyskinesia—irreversible jerky facial and body movements caused by antipsychotics—was ignored by the psychiatric profession for about 20 years until George Crane's 1974 Science paper called out the problem, despite the drug-induced symptoms making patients appear visibly mentally ill to the public
- The 2005 CATIE study found that newer, expensive second-generation antipsychotics were no more efficacious than older, cheap first-generation drugs, and 67-82% of patients dropped out due to drug ineffectiveness or intolerable side effects, contradicting industry marketing claims
- Second-generation antipsychotics replaced tardive dyskinesia with different severe side effects—weight gain of 10-50 pounds leading to metabolic syndrome and diabetes—demonstrating that psychiatric medications involve unpredictable individual cost-benefit analyses with no biological markers to predict who will benefit or suffer harm
Topics
Transcript
[0:02] This is the lay of the land. We talked about some of the darkness. >> Yes. >> Lobotomies and so on. There is some talk therapy ideas of psychoanalysis, and then there is from the clinical psychologist side, cognitive behavioral therapy. Then starts to emerge the psychopharmacology that challenges this whole shebang of talk therapy, period. And can you talk about the accidental origins of psychopharmacology? [0:34] >> Yes. >> That challenges this whole thing. >> Hardly anybody had conceived of the idea that drugs could be used to treat mental illness. Drugs had been used in the mental hospitals back in the 19th and 20th centuries, but they were usually things that were used to control patients, to…
Full transcript available for MurmurCast members
Sign Up to AccessMore from Lex Clips
Freud's radical theory of the unconscious mind | Andrew Scull and Lex Fridman
Andrew Scull discusses Freud's development of psychoanalytic theory, including his structural model of the mind (id, ego, superego) and his theoretical innovations like dream interpretation and Freudian slips. The conversation explores how Freudian ideas gained popularity among intellectuals and artists in the 1920s-30s, particularly following WWI's shell shock crisis, despite remaining largely outside mainstream psychiatric institutions that dealt with severely disturbed patients.
Hitler's role in development of psychoanalysis and psychology | Andrew Scull and Lex Fridman
This discussion traces how Nazi persecution of psychoanalysts during WWII led to their migration to America, where the field underwent a dramatic transformation. Clinical psychologists emerged as competitors to psychoanalysts by developing shorter, measurable, evidence-based therapies like cognitive behavioral therapy (CBT) that focused on treating symptoms rather than reconstructing entire personalities.
Prison system is an insane asylum | Andrew Scull and Lex Fridman
Andrew Scull discusses how the deinstitutionalization of psychiatric asylums has failed people with serious mental illness, leading to a crisis where the largest psychiatric facilities in the US are now jails rather than hospitals. He argues that while asylums had serious problems, the promised 'community care' alternative never materialized, leaving vulnerable populations cycling through brief hospitalizations, homelessness, and incarceration.
Sigmund Freud vs Carl Jung: Why Freud hated Jung | Andrew Scull and Lex Fridman
This conversation explores the history of psychoanalysis through Sigmund Freud's foundational work on hysteria and his later contentious relationship with Carl Jung. It traces how Freud developed psychoanalytic theory from the case of Anna O, emphasizing repressed memories and trauma, before eventually excommunicating Jung from his inner circle due to ideological and personal conflicts.
Mental illness in women vs men | Andrew Scull and Lex Fridman
Andrew Scull discusses how psychiatric treatments like ECT, lobotomy, and forced treatments were disproportionately applied to women rather than men throughout the 20th century, while men received different diagnoses like personality disorders. He notes that cultural representations, particularly films, significantly influenced public perception and clinical adoption of these treatments.